This brand name is authorized in Japan
The drug MIRACLID contains one active pharmaceutical ingredient (API):
|
1
Ulinastatin
UNII OR3S9IF86U - ULINASTATIN
|
|
Ulinastatin is a serine protease inhibitor that reduces the pro-inflammatory response as a result of sepsis, acute pancreatitis, trauma or surgery. It inhibits coagulation and fibrinolysis and promotes microperfusion. Thus, ulinastatin is an effective agent for immune modulation to prevent organ dysfunction and promote homeostasis. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B02AB05 | B Blood and blood forming organs → B02 Antihemorrhagics → B02A Antifibrinolytics → B02AB Proteinase inhibitors | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3999405A2077, 3999405A3073 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
